Mycn Knockin mouse models

Encoding N-Myc, Mycn is the mouse ortholog of human MYCN and produces a basic helix-loop-helix leucine zipper factor that heterodimerizes with Max, occupies E-box elements, and drives ribosome biogenesis and cell cycle programs in neural crest, neuroblast, and cerebellar progenitors; like c-Myc it carries the Thr58 and Ser62 phosphodegron read by Fbxw7, but Aurora kinase A binding stabilizes the protein against that pathway, which is the mechanistic basis for Aurora A inhibitor strategies in MYCN-amplified disease. Genomic amplification defines high-risk neuroblastoma and also occurs in medulloblastoma and neuroendocrine prostate cancer. Homozygous nulls die in mid-gestation with neural, cardiac, and lung defects, so conditional deletion is required for progenitor studies, whereas lineage-restricted overexpression modeled on tyrosine hydroxylase promoter-driven designs remains the standard tumor-initiating allele, and a Thr58Ala knockin isolates degron control from expression level. Myc can substitute at the endogenous locus, so paralog dosage and driver specificity govern the phenotype.

Mycn knockin models place a defined sequence at the endogenous locus. Expression stays under native regulation, which matters for reporters, tags, and precise allele swaps.